Summary of articles from the ISTH 2020 Virtual Congress:
- Stals MAM, et al. Thrombotic Complications: SARS-COV-2 versus Influenza. LB/CO01.4, ISTH Virtual Congress 2020, 12-14 July.
- Königs C, et al. Safety and Efficacy of rFVIIIFc in Untreated Patients with Haemophilia A. OC 03.2, ISTH 2020 Virtual Congress, 12-14 July.
- Nopp S, et al. Outpatient Pulmonary Rehabilitation post-Pulmonary Embolism. PB2457, ISTH Virtual Congress 2020, 12-14 July.
- Al-Samkari H, et al. ALK Rearrangement is a Major Risk Factor for Venous and Arterial Thrombosis in Non-Small Cell Lung Cancer. OC 10.2.ISTH 2020 Virtual Congress, 12-14 July.
- Moustafa F, et al. DOAC bleeding events: atrial fibrillation vs venous thromboembolism. PB1128, ISTH 2020 Virtual Congress, 12-14 July.
- Beyer-Westendorf J, et al. Pregnancy and DOACs. SOA 10.03, ISTH Virtual Congress 2020, 12-14 July.
Posted on
Previous Article
« DNA-methylation test shows promise in bladder-cancer detection, monitoring Next Article
Rivaroxaban superior to enoxaparin in preventing VTE in non-major orthopaedic surgery »
« DNA-methylation test shows promise in bladder-cancer detection, monitoring Next Article
Rivaroxaban superior to enoxaparin in preventing VTE in non-major orthopaedic surgery »
Table of Contents: ISTH 2020
Featured articles
Haemophilia and Rare Bleeding Disorders
Novel gene therapy leads to normal FIX activity levels in severe haemophilia B
Haemophilia gene therapy: progress and obstacles
Recombinant factor VIII safe and effective in PUPs A-LONG study
What’s New in Anticoagulation
Finding the sweet spot of anticoagulation in AF patients with ACS
Lower embryopathy risk with DOAC versus VKA during pregnancy
Higher thrombotic risk in NSCLC patient with ALK rearrangement
COVID-19 and Thrombosis
Crosstalk between inflammation and coagulation in severe COVID-19 infections
COVID-19 associated with higher VTE rates relative to influenza
Therapeutic anticoagulation not associated with lower mortality rates in COVID-19 ICU patients
COVID-19 not associated with heightened VTE risk after discharge
What’s New in Venous Thromboembolism
Residual pulmonary obstruction may predict risk of VTE recurrence
Less diagnostic delay in CTEPH diagnosis with novel algorithm
Risk of checkpoint inhibitor-associated thromboembolic events important for cancer prognosis
Pearls of the Posters
Surgical bleeding risk most important determinant of bleeding outcomes
Similar bleeding rates in patients with VTE and AF treated with DOACs
Physical rehabilitation improves health outcomes after pulmonary embolism
Guidelines adherence reduces bleeding risk after surgery and childbirth for VWD patients
Factor V Leiden mutation linked to atrial fibrillation
Increased rates of arterial thromboembolism in cancer patients
Related Articles
September 8, 2020
Similar bleeding rates in patients with VTE and AF treated with DOACs
© 2024 Medicom Medical Publishers. All rights reserved. Terms and Conditions | Privacy Policy
HEAD OFFICE
Laarderhoogtweg 25
1101 EB Amsterdam
The Netherlands
T: +31 85 4012 560
E: publishers@medicom-publishers.com